A Phase II, Stratified, Randomized, Double-Blind, Multi-Center Study of the Safety and Efficacy of Adefovir Dipivoxil (ADF) at Two Dose Levels in Triple Combination Therapies With Protease Inhibitors (PI) and Nucleoside Reverse Transcriptase Inhibitors (RTI) for the Treatment of HIV-Infected Patient

North Shore Community Hosp, Manhassett

Univ of Pennsylvania, Philadelphia

George Washington Med Ctr, Washington D.C.

Johns Hopkins Univ School of Medicine, Baltimore

Associates of Med and Mental Health, Tulsa

Univ of Texas Southwestern Med Ctr of Dallas, Dallas

Phoenix Body Positive, Phoenix

Krauss Med Partners / Dept of Research and Development, Los Angeles

Davies Med Ctr, San Francisco

UCLA Care Ctr, Los Angeles

Blick Med Associates, Greenwich

Univ of Massachusetts Med Ctr, Worcester

Mem Hosp of Rhode Island, Pawtucket

Hosp Regional de Ponce - Area Vieja, Ponce

San Juan AIDS Program, Santruce